Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -6.64% is 96% above its 5-year average of -148.77%, near the low end of its 5-year range (-8182.20%–32264.66%).
185.33% below its 12-month average of 7.78%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 17.84%.
NET PROFIT MARGIN
-6.64%
NET PROFIT MARGIN AVG TTM
7.78%
NET PROFIT MARGIN AVG 3Y
-97.91%
NET PROFIT MARGIN AVG 5Y
-148.77%
NET PROFIT MARGIN AVG 10Y
-376.93%
NET PROFIT MARGIN AVG 15Y
-366.74%
NET PROFIT MARGIN AVG 20Y
-286.88%
CURRENT VS TTM AVG
-185.33%
CURRENT VS 3Y AVG
+93.22%
CURRENT VS 5Y AVG
+95.54%
CURRENT VS 10Y AVG
+98.24%
CURRENT VS 15Y AVG
+98.19%
CURRENT VS 20Y AVG
+97.69%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-2453.85%
vs the sector median at left
TherapeuticsMD, Inc.
Market Cap
$23.26M
Net Profit Margin
-6.64%
TTM Avg
7.78%
3Y Avg
-97.91%
5Y Avg
-148.77%
Market Cap
$22.92M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$23.88M
Net Profit Margin
3967.77%
TTM Avg
1344.00%
3Y Avg
468.01%
5Y Avg
273.57%
Market Cap
$22.13M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$24.59M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$22.00M
Net Profit Margin
-24.76%
TTM Avg
-22.59%
3Y Avg
-21.34%
5Y Avg
-47.79%
Market Cap
$24.91M
Net Profit Margin
0.00%
TTM Avg
-481.06%
3Y Avg
-1941.22%
5Y Avg
-2233.39%
Market Cap
$25.30M
Net Profit Margin
-355.17%
TTM Avg
-499.98%
3Y Avg
-419.63%
5Y Avg
-405.79%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | $23.26M | -6.64% | 7.78% | -97.91% | -148.77% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kyntra Bio, Inc. (KYNB)vs › | $23.88M | 3967.77% | 1344.00% | 468.01% | 273.57% |
| LeonaBio, Inc. (LONA)vs › | $22.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| Modular Medical, Inc. (MODD)vs › | $22.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.59M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | -24.76% | -22.59% | -21.34% | -47.79% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.91M | 0.00% | -481.06% | -1941.22% | -2233.39% |
| InspireMD, Inc. (NSPR)vs › | $25.30M | -355.17% | -499.98% | -419.63% | -405.79% |
| iTonic Holdings Ltd. (ITOC)vs › | $26.05M | -974.68% | -561.03% | -287.02% | -224.14% |
Operating Margin
-139.4%
Net Profit Margin
-6.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 17.84% |
| 2026-03-31 | 13.12% |
| 2025-12-31 | -69.32% |
| 2025-09-30 | 19.39% |
| 2025-06-30 | 57.88% |
| 2025-03-31 | -166.16% |
| 2024-12-31 | 37.78% |
| 2024-09-30 | -111.33% |
| 2024-06-30 | -465.81% |
| 2024-03-31 | -234.50% |
| 2023-12-31 | -175.90% |
| 2023-09-30 | 6373.58% |
| 2023-06-30 | -552.40% |
| 2023-03-31 | -866.11% |
| 2022-12-31 | 6744.97% |
| 2022-09-30 | -8182.20% |
| 2022-06-30 | 32264.66% |
| 2022-03-31 | -7053.38% |
| 2021-12-31 | -230.00% |
| 2021-09-30 | -186.65% |
| 2021-06-30 | -185.44% |
| 2021-03-31 | -198.24% |
| 2020-12-31 | -186.41% |
| 2020-09-30 | -168.61% |
| 2020-06-30 | -485.71% |
| 2020-03-31 | -464.04% |
| 2019-12-31 | -310.88% |
| 2019-09-30 | -134.77% |
| 2019-06-30 | -908.66% |
| 2019-03-31 | -1001.01% |
| 2018-12-31 | -773.96% |
| 2018-09-30 | -1025.05% |
| 2018-06-30 | -882.78% |
| 2018-03-31 | -646.68% |
| 2017-12-31 | -519.55% |
| 2017-09-30 | -331.96% |
| 2017-06-30 | -462.94% |
| 2017-03-31 | -530.84% |
| 2016-12-31 | -508.90% |
| 2016-09-30 | -451.90% |
| 2016-06-30 | -479.06% |
| 2016-03-31 | -424.52% |
| 2015-12-31 | -310.54% |
| 2015-09-30 | -375.18% |
| 2015-06-30 | -561.63% |
| 2015-03-31 | -466.91% |
| 2014-12-31 | -382.90% |
| 2014-09-30 | -425.97% |
| 2014-06-30 | -290.51% |
| 2014-03-31 | -324.43% |
| 2013-12-31 | -292.69% |
| 2013-09-30 | -334.38% |
| 2013-06-30 | -288.80% |
| 2013-03-31 | -414.76% |
| 2012-12-31 | -461.62% |
| 2012-09-30 | -410.37% |
| 2012-06-30 | -1446.63% |
| 2012-03-31 | -1841.45% |
| 2011-12-31 | -641.93% |
| 2011-09-30 | -275.55% |
| 2011-06-30 | -209.79% |
| 2011-03-31 | -159.38% |
| 2010-12-31 | -534.53% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | -5973.23% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 38.27% |
| 2007-06-30 | 28.98% |
| 2007-03-31 | 24.55% |
| 2006-12-31 | 43.50% |
| 2006-09-30 | 41.85% |
| 2006-06-30 | 36.22% |
| 2006-03-31 | 24.84% |
| 2005-12-31 | 32.89% |
| 2005-09-30 | 43.94% |
| 2005-06-30 | 4.71% |
| 2005-03-31 | 39.17% |
| 2004-12-31 | 48.17% |
| 2004-09-30 | 30.96% |
| 2004-06-30 | 19.74% |
| 2004-03-31 | -18.75% |
| 2003-12-31 | 23.29% |
| 2003-09-30 | 46.60% |
| 2003-06-30 | 10.15% |
| 2003-03-31 | 10.72% |
| 2002-12-31 | 37.14% |
| 2002-09-30 | 31.36% |
